Early safety indicators of COVID-19 convalescent plasma in 5000 patients

BACKGROUND: Convalescent plasma is the only antibody-based therapy currently available for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence and sound biological plausibility. Although promising, convalescent plasma has not yet been shown to be safe as a treatmen...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Invest
Main Authors: Joyner, Michael J., Wright, R. Scott, Fairweather, DeLisa, Senefeld, Jonathon W., Bruno, Katelyn A., Klassen, Stephen A., Carter, Rickey E., Klompas, Allan M., Wiggins, Chad C., Shepherd, John R.A., Rea, Robert F., Whelan, Emily R., Clayburn, Andrew J., Spiegel, Matthew R., Johnson, Patrick W., Lesser, Elizabeth R., Baker, Sarah E., Larson, Kathryn F., Ripoll, Juan G., Andersen, Kylie J., Hodge, David O., Kunze, Katie L., Buras, Matthew R., Vogt, Matthew N.P., Herasevich, Vitaly, Dennis, Joshua J., Regimbal, Riley J., Bauer, Philippe R., Blair, Janis E., Van Buskirk, Camille M., Winters, Jeffrey L., Stubbs, James R., Paneth, Nigel S., Verdun, Nicole C., Marks, Peter, Casadevall, Arturo
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Clinical Investigation 2020
Fag:
Clinical Medicine
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456238/
https://ncbi.nlm.nih.gov/pubmed/32525844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI140200
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker